A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer |
Yokoyama, Yoshihito
(Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine)
Shigeto, Tatsuhiko (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Miura, Rie (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Kobayashi, Asami (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Mizunuma, Makito (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Yamauchi, Aisa (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Futagami, Masayuki (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) Mizunuma, Hideki (Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine) |
1 | del Carmen MG, Rizvi I, Chang Y, et al (2005). Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst, 97, 1516-24. DOI |
2 | Gallagher-Colombo SM, Miller J, Cengel KA, et al (2015). Erlotinib Pretreatment Improves Photodynamic Therapy of Non-Small Cell Lung Carcinoma Xenografts via multiple Mechanisms. Cancer Res, 75, 3118-26. DOI |
3 | Ikeda N, Usuda J, Kato H, et al (2011). New aspects of photodynamic therapy for central type early stage lung cancer. Lasers Surg Med, 43, 749-54. DOI |
4 | Kroep JR, Nortier JW (2012). The role of bevacizumab in advanced epithelial ovarian cancer. Curr Pharm Des, 18, 3775-83. DOI |
5 | Lee CK, Lord S, Grunewald T, et al (2015). Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial. Gynecol Oncol, 136, 18-24. DOI |
6 | Lucena SR, Salazar N, Gracia-Cazana T, et al (2015). Combined treatments with photodynamic therapy for non-melanoma skin cancer. Int J Mol Sci, 16, 25912-33. DOI |
7 | Li Z, Sun L, Lu Z, et al (2015). Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system. Int J Oncol, 47, 1070-6. DOI |
8 | Liu AH, Sun X, Wei XQ, et al (2013). Efficacy of multiple lowdose photodynamic TMPYP4 therapy on cervical cancer tumour growth in nude mice. Asian Pac J Cancer Prev, 14, 5371-4. DOI |
9 | Peng Q, Warloe T, Moan J, et al (2001). Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res, 61, 5824-32. |
10 | Rizvi I, Celli JP, Evans CL, et al (2010). Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res, 70, 9319-28. DOI |
11 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI |
12 | Spinelli P, Dal Fante M, Mancini A (1992). Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience. Semin Surg Oncol, 8, 204-13. DOI |
13 | Wakui M, Yokoyama Y, Wang H, et al (2010). Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers. J Cancer Res Clin Oncol, 136, 1143-50. DOI |
14 | Wang C, Chen X, Wu J, et al (2013). Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma. J Photochem Photobiol B, 127, 61-7. DOI |
15 | Wei XQ, Ma HQ, Liu AH, et al (2013). Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells. Asian Pac J Cancer Prev, 14, 3023-8. DOI |
16 | Weiss A, Bonvin D, Berndsen RH, et al (2015). Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy. Sci Rep, 5, 8990. DOI |
17 | Yokoyama Y, Xin B, Shigeto T, et al (2007). Clofibric acid, a peroxisome proliferator activated receptor a ligand, inhibits growth of human ovarian cancer. Mol Cancer Ther, 6, 1379-86. DOI |
18 | Yokoyama Y, Hirakawa H, Wang H, et al (2012). Is omentectomy mandatory in the operation for ovarian cancer? Eur J Obstet Gynecol Reprod Biol, 164, 89-92. DOI |
19 | Akeson M, Zetterqvist BM, Dahllöf K, et al (2008). Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohortstudy of all patients in western Sweden with long-term follow-up. Acta ObstetGynecol Scand, 87, 1343-52. DOI |
20 | Casson AG (2009). Photofrin PDT for early stage esophageal cancer: a new standard of care? Photodiagnosis Photodyn Ther, 6, 155-6. DOI |
21 | Choi MC, Lee C, Kim SJ (2014). Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia:a systemic review. Photodiagnosis Photodyn Ther, 11, 479-80. DOI |
22 | Yu J, Cao XF, Zheng Y, et al (2014). Anti-VEGF Therapy with Bevacizumab--limited cardiovascular toxicity. Asian Pac J Cancer Prev, 15, 10769-72. |